Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)

NCT03525418 is registered in ClinicalTrials.gov with Longeveron Inc. as lead sponsor.

NCT NCT03525418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03525418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)
Lead sponsor
Longeveron Inc.
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 21, 2018
Completion date
December 31, 2025
Enrollment
10 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hlhs